Aptus Pharma Schedules Q2 FY27 Earnings Conference Call for 26th Oct'26
Aptus Pharma Ltd 路 Intimation 路 26 Oct 2026, 5:00 pm
Aptus Pharma Schedules Q2 FY27 Earnings Conference Call for 26th Oct'26 Aptus Pharma Limited has scheduled an audio earnings conference call on 26th Oct'26 at 5:00 PM IST to discuss its financial performance for Q2 and H1 FY27, ended 30th Sep'26. Key leadership, including Managing Director Tejash Hathi, CEO Ghanshyam Pansuriya, CFO Kapil Chandarana, and VP Domestic Nirav Pandya, will present updates on recent business developments, growth strategies, and the forward business outlook. Registered access is available via Diamond Pass, with general dial-in access provided under participant PIN 1954595#.
Original exchange filing (PDF)
More announcements from Aptus Pharma Ltd
- Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations, 2015 路 12 Nov 2026
- Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting for .... 路 06 Nov 2026
- Receipt of In-Principle Approval for Preferential Issue 路 31 Oct 2026
- Transcript for Earning Call for the Quarter and Half Year ended on September 30, 2026 路 30 Oct 2026
- Audio recording of the Earnings Call dated October 26, 2026 路 27 Oct 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 23 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
